TipRanks
Go Ultimate75% OFF

Helus Pharma (HELP) Stock Forecast & Price Target

2,625 Followers
See the Price Targets and Ratings of:

HELP Analyst Ratings

Strong Buy
7Ratings
7Buy0Hold0Sell
Based on 7 analysts giving stock ratings to Helus Pharma in the past 3 months

HELP Stock 12 Month Forecast

$41.71▲(365.56% Upside)
Based on 7 Wall Street analysts offering 12 month price targets for Helus Pharma in the last 3 months. The average price target is $41.71 with a high forecast of $70.00 and a low forecast of $16.00. The average price target represents a 365.56% change from the last price of $8.96.
Highest Price Target$70.00Average Price Target$41.71Lowest Price Target$16.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for HELP
Price TargetFollowArticle
Barclays$35buy290.62%UpsideReiterated11/03/26
Guggenheim Analyst forecast on HELPUnknown AnalystNot RankedGuggenheim$45buy402.23%UpsideReiterated10/23/26
H.C. Wainwright$70buy681.25%UpsideReiterated10/22/26
Canaccord Genuity$42buy368.75%UpsideReiterated10/22/26
Jefferies$22buy145.54%UpsideReiterated10/05/26
TD Cowen$62buy591.96%UpsideReiterated09/21/26
Wells Fargo$16buy78.57%UpsideReiterated08/31/26
Bloom Burton$47buy424.55%UpsideReiterated07/21/26
Alliance Global Partners$30→$15buy67.41%UpsideReiterated07/14/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AXGNAxoGen
OVIDOvid Therapeutics
IRLAIRulya Therapeutics
ZYMEZymeworks
HELPHelus Pharma

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Helus Pharma

3 Months
Sumant Kulkarni
Sumant KulkarniCanaccord Genuity
Success Rate10/22 ratings generated profit
45%
Average Return
+1.59%

Copying Sumant Kulkarni's trades and holding each position for 3 Months would result in 45.45% of your transactions generating a profit, with an average return of +1.59% per trade.

1 Year
Patrick Trucchio
Patrick TrucchioH.C. Wainwright
Success Rate8/16 ratings generated profit
50%
Average Return
+11.25%

Copying Patrick Trucchio's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +11.25% per trade.

2 Years
Patrick Trucchio
Patrick TrucchioH.C. Wainwright
Success Rate10/16 ratings generated profit
63%
Average Return
+12.94%

Copying Patrick Trucchio's trades and holding each position for 2 Years would result in 62.50% of your transactions generating a profit, with an average return of +12.94% per trade.

HELP Analyst Recommendation Trends

05101520Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for HELP
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy811141311
Buy01110
Hold00000
Sell00000
Strong Sell00000
total812151411

In the current month, HELP has received 11 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. HELP average Analyst price target in the past 3 months is 41.71.

HELP Financial Forecast

$-3$-2.25$-1.5$-0.75$0Q3 2026Q1 2027Q2 2027
High$-0.41
Consensus$-0.70
Low$-0.91

HELP Earnings Forecast

Next quarter’s earnings estimate for HELP is -$0.70 with a range of -$0.91 to -$0.41. The previous quarter’s EPS was -$0.89. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$-1$-0.5$0$0.5$1Q3 2026Q1 2027Q2 2027
High$0.00
Consensus$0.00
Low$0.00

HELP Sales Forecast

Next quarter’s sales forecast for HELP is $0 with a range of $0 to $0. The previous quarter’s sales results were $0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

HELP Stock Forecast FAQ

What is HELP’s average 12-month price target, according to analysts?
Based on analyst ratings, Helus Pharma’s 12-month average price target is $41.71.
What is HELP’s upside potential, based on the analysts’ average price target?
Helus Pharma has 365.56% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is HELP a Buy, Sell or Hold?
Helus Pharma has a consensus rating of Strong Buy which is based on 7 buy ratings, 0 hold ratings and 0 sell ratings.
What is Helus Pharma’s price target?
The average price target for Helus Pharma is $41.71. This is based on 7 12-month price targets, issued in the past 3 months. The highest analyst price target is $70.00, the lowest forecast is $16.00. The average price target represents a 365.56% increase from the current price of $8.96.
What do analysts say about Helus Pharma?
Helus Pharma’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Street analysts.
How can I buy shares of HELP?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.